← Back
DarioHealth
DRIO · listed on Nasdaq · worth $66.34 million
$3.00
−9.37% on Oct 30
One insider buy in the last year, $100K in all. None in the last two weeks.
Green dot = an insider bought◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
7.7M shares
78% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought DarioHealth stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Director
Dennis Matheis
Bought $100K on Jul 23 — 14,430 shares at $6.93, 34% of what they now own.
1 of 1 earlier purchase did better than the S&P 500
All reports
Every insider trade and SEC report we hold for DarioHealth.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Analysts, earnings and news
Analysts' price target
$14.00 average
5 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
3 of 4 quarters above
Q2 '26−$0.73 a share+$0.03
Q1 '26−$0.95 a share−$0.10
Q4 '25−$0.77 a share+$0.82
Q3 '25−$2.22 a share+$0.20